Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer

NCT01876069 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DEVICE: 22 gauge ProCore needle aspiration
DEVICE: 22 gauge Fine needle aspiration

Sponsor

Samsung Medical Center

Collaborators

[object Object]